BIOMAT Database Logo BIOMAT Database Logo

Discovery of Novel Benzimidazole and Indazole Analogues as Tubulin Polymerization Inhibitors with Potent Anticancer Activities. 2021

Yichang Ren, and Yuxi Wang, and Gang Li, and Zherong Zhang, and Lingling Ma, and Binbin Cheng, and Jianjun Chen
School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Screening, Southern Medical University, Guangzhou 510515, China.

Novel indazole and benzimidazole analogues were designed and synthesized as tubulin inhibitors with potent antiproliferative activities. Among them, compound 12b exhibited the strongest inhibitory effects on the growth of cancer cells with an average IC50 value of 50 nM, slightly better than colchicine. 12b exhibited nearly equal potency against both, a paclitaxel-resistant cancer cell line (A2780/T, IC50 = 9.7 nM) and the corresponding parental cell line (A2780S, IC50 = 6.2 nM), thus effectively overcoming paclitaxel resistance in vitro. The crystal structure of 12b in complex with tubulin was solved to 2.45 Å resolution by X-ray crystallography, and its direct binding was confirmed to the colchicine site. Furthermore, 12b displayed significant in vivo antitumor efficacy in a melanoma tumor model with tumor growth inhibition rates of 78.70% (15 mg/kg) and 84.32% (30 mg/kg). Collectively, this work shows that 12b is a promising lead compound deserving further investigation as a potential anticancer agent.

UI MeSH Term Description Entries
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001562 Benzimidazoles Compounds with a BENZENE fused to IMIDAZOLES.
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Yichang Ren, and Yuxi Wang, and Gang Li, and Zherong Zhang, and Lingling Ma, and Binbin Cheng, and Jianjun Chen
Discovery of novel N-benzylbenzamide derivatives as tubulin polymerization inhibitors with potent antitumor activities.
April 2021, European journal of medicinal chemistry,
Yichang Ren, and Yuxi Wang, and Gang Li, and Zherong Zhang, and Lingling Ma, and Binbin Cheng, and Jianjun Chen
Discovery of novel coumarin-indole derivatives as tubulin polymerization inhibitors with potent anti-gastric cancer activities.
August 2022, European journal of medicinal chemistry,
Yichang Ren, and Yuxi Wang, and Gang Li, and Zherong Zhang, and Lingling Ma, and Binbin Cheng, and Jianjun Chen
Discovery of biarylaminoquinazolines as novel tubulin polymerization inhibitors.
June 2014, Journal of medicinal chemistry,
Yichang Ren, and Yuxi Wang, and Gang Li, and Zherong Zhang, and Lingling Ma, and Binbin Cheng, and Jianjun Chen
The discovery of water-soluble indazole derivatives as potent microtubule polymerization inhibitors.
December 2023, European journal of medicinal chemistry,
Yichang Ren, and Yuxi Wang, and Gang Li, and Zherong Zhang, and Lingling Ma, and Binbin Cheng, and Jianjun Chen
Novel indole-bearing combretastatin analogues as tubulin polymerization inhibitors.
March 2013, Organic and medicinal chemistry letters,
Yichang Ren, and Yuxi Wang, and Gang Li, and Zherong Zhang, and Lingling Ma, and Binbin Cheng, and Jianjun Chen
Discovery of Novel Acridane-Based Tubulin Polymerization Inhibitors with Anticancer and Potential Immunomodulatory Effects.
January 2023, Journal of medicinal chemistry,
Yichang Ren, and Yuxi Wang, and Gang Li, and Zherong Zhang, and Lingling Ma, and Binbin Cheng, and Jianjun Chen
Discovery of novel quinoline-based analogues of combretastatin A-4 as tubulin polymerisation inhibitors with apoptosis inducing activity and potent anticancer effect.
December 2021, Journal of enzyme inhibition and medicinal chemistry,
Yichang Ren, and Yuxi Wang, and Gang Li, and Zherong Zhang, and Lingling Ma, and Binbin Cheng, and Jianjun Chen
Design, synthesis and evaluation of novel bis-substituted aromatic amide dithiocarbamate derivatives as colchicine site tubulin polymerization inhibitors with potent anticancer activities.
February 2022, European journal of medicinal chemistry,
Yichang Ren, and Yuxi Wang, and Gang Li, and Zherong Zhang, and Lingling Ma, and Binbin Cheng, and Jianjun Chen
Discovery of chalcone analogues as novel NLRP3 inflammasome inhibitors with potent anti-inflammation activities.
July 2021, European journal of medicinal chemistry,
Yichang Ren, and Yuxi Wang, and Gang Li, and Zherong Zhang, and Lingling Ma, and Binbin Cheng, and Jianjun Chen
Discovery of Novel 4-Arylisochromenes as Anticancer Agents Inhibiting Tubulin Polymerization.
October 2018, ACS medicinal chemistry letters,
Copied contents to your clipboard!